Found: 29
Select item for more details and to access through your institution.
Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 4, p. 548, doi. 10.1002/ijc.2910610420
- By:
- Publication type:
- Article
Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Fourteenth Meeting of the <italic>Network Italiano per la Bioterapia dei Tumori (NIBIT)</italic> on Cancer Bio-Immunotherapy, Siena, Italy, October 13-15, 2016.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1021, doi. 10.1007/s00262-013-1418-6
- By:
- Publication type:
- Article
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 41, doi. 10.1007/s00262-011-1089-0
- By:
- Publication type:
- Article
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy).
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 4, p. 467, doi. 10.1007/s00262-010-0958-2
- By:
- Publication type:
- Article
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1297, doi. 10.1007/s00262-008-0642-y
- By:
- Publication type:
- Article
Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 9, doi. 10.1007/s00262-001-0249-z
- By:
- Publication type:
- Article
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6557, doi. 10.1038/sj.onc.1206813
- By:
- Publication type:
- Article
Epigenetic targets for immune intervention in human malignancies.
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6484, doi. 10.1038/sj.onc.1206956
- By:
- Publication type:
- Article
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6564, doi. 10.1038/sj.onc.1206960
- By:
- Publication type:
- Article
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.
- Published in:
- Cardiovascular Research, 2010, v. 86, n. 1, p. 12, doi. 10.1093/cvr/cvp332
- By:
- Publication type:
- Article
Is it the primetime for endoglin (CD105) in the clinical setting?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-82
- By:
- Publication type:
- Article
Methylation-regulated expression of HLA class I antigens in melanoma.
- Published in:
- International Journal of Cancer, 2003, v. 105, n. 3, p. 430, doi. 10.1002/ijc.11077
- By:
- Publication type:
- Article
Unbalanced expression of HLA-A and -B antigens: A specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-γ.
- Published in:
- International Journal of Cancer, 2001, v. 91, n. 4, p. 500, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1076>3.0.CO;2-I
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-116
- By:
- Publication type:
- Article
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.
- Published in:
- Journal of Cellular Physiology, 2010, v. 223, n. 2, p. 352, doi. 10.1002/jcp.22040
- By:
- Publication type:
- Article
Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications.
- Published in:
- Journal of Cellular Physiology, 2007, v. 212, n. 2, p. 330, doi. 10.1002/jcp.21066
- By:
- Publication type:
- Article
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications.
- Published in:
- Journal of Cellular Physiology, 2006, v. 207, n. 1, p. 58, doi. 10.1002/jcp.20540
- By:
- Publication type:
- Article
Methylation‐regulated expression of cancer testis antigens in primary effusion lymphoma: Immunotherapeutic implications L. Calabrò and E. Fonsatti contributed equally to this work.
- Published in:
- Journal of Cellular Physiology, 2005, v. 202, n. 2, p. 474, doi. 10.1002/jcp.20133
- By:
- Publication type:
- Article
Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma (This study is dedicated to the memory of Raffaele Tecce.).
- Published in:
- Journal of Cellular Physiology, 2004, v. 200, n. 2, p. 272, doi. 10.1002/jcp.20015
- By:
- Publication type:
- Article
Differential levels of soluble endoglin (CD105) in myeloid malignancies.
- Published in:
- Journal of Cellular Physiology, 2003, v. 194, n. 2, p. 171, doi. 10.1002/jcp.10200
- By:
- Publication type:
- Article
Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.
- Published in:
- Journal of Cellular Physiology, 2002, v. 190, n. 2, p. 200, doi. 10.1002/jcp.10050
- By:
- Publication type:
- Article
Endoglin: An accessory component of the TGF-β-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
- Published in:
- Journal of Cellular Physiology, 2001, v. 188, n. 1, p. 1, doi. 10.1002/jcp.1095
- By:
- Publication type:
- Article
Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement.
- Published in:
- Journal of Cellular Physiology, 2000, v. 185, n. 3, p. 317, doi. 10.1002/1097-4652(200012)185:3<317::AID-JCP1>3.0.CO;2-L
- By:
- Publication type:
- Article
The overlooked 'nonclassical' functions of major histocompatibility complex (MHC) class II antigens in immune and nonimmune cells.
- Published in:
- Journal of Cellular Physiology, 1999, v. 179, n. 3, p. 251, doi. 10.1002/(SICI)1097-4652(199906)179:3<251::AID-JCP2>3.0.CO;2-P
- By:
- Publication type:
- Article
Effects of Nitrendipine in Patients with Chronic Renal Failure.
- Published in:
- American Journal of Nephrology, 1986, v. 6, n. S1, p. 162, doi. 10.1159/000167242
- By:
- Publication type:
- Article